Suzuki, M., Cao, K., Kato, S., Komizu, Y., Mizutani, N., Tanaka, K., … Takahashi, T. (2019). Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. J Clin Invest, 129(8), 3464. https://doi.org/10.1172/JCI131245

Suzuki, Motoshi, Ke Cao, Seiichi Kato, Yuji Komizu, Naoki Mizutani, Kouji Tanaka, Chinatsu Arima, et al. “Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.” J Clin Invest 129, no. 8 (July 2, 2019): 3464. https://doi.org/10.1172/JCI131245.

Suzuki M, Cao K, Kato S, Komizu Y, Mizutani N, Tanaka K, et al. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. J Clin Invest. 2019 Jul 2;129(8):3464.

Suzuki, Motoshi, et al. “Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.” J Clin Invest, vol. 129, no. 8, July 2019, p. 3464. Pubmed, doi:10.1172/JCI131245.

Suzuki M, Cao K, Kato S, Komizu Y, Mizutani N, Tanaka K, Arima C, Tai MC, Yanagisawa K, Togawa N, Shiraishi T, Usami N, Taniguchi T, Fukui T, Yokoi K, Wakahara K, Hasegawa Y, Mizutani Y, Igarashi Y, Inokuchi J-I, Iwaki S, Fujii S, Satou A, Matsumoto Y, Ueoka R, Tamiya-Koizumi K, Murate T, Nakamura M, Kyogashima M, Takahashi T. Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells. J Clin Invest. 2019 Jul 2;129(8):3464.